Breast cancer (BC) is the most common and malignant cancer in women (1) and classified into three subtypes depending on certain molecular biomarkers (2): estrogen receptor (ER)/progesterone receptor (PR)-positive, HER2-positive, and triple-negative breast cancers (TNBCs). This evidence concerns the gene ESR1 and breast carcinoma.